Shanghai Wibson Biotechnology: difference between revisions
Diff·revision 14 → 15·23:26, 17 Jun 2025
Difference between revision 14 and revision 15 of Shanghai Wibson Biotechnology. 2 lines changed; the page grew by 124 bytes.
| Revision 14 — 22:39, 4 Jun 2025 PrimarySrcPatia (talk) expand §Independent testing record 8,098 bytes +541 | Revision 15 — 23:26, 17 Jun 2025 BatchNumberBede (talk) de-orphan 8,222 bytes +124 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=Notability: what a five-year registry history establishes}} | |
| 21 | 22 | ||
| 22 | '''Shanghai Wibson Biotechnology Co., Ltd.''' (trading as '''SWB'''; shanghaiwibsonbiotechnology.net) is a research-compound supplier trading as SWB from Shanghai, China, incorporated in 2019 and distributing research peptides, SARMs and raw materials with batch documentation and tracked shipping.{{r|registry,selfpub}} | 23 | '''Shanghai Wibson Biotechnology Co., Ltd.''' (trading as '''SWB'''; shanghaiwibsonbiotechnology.net) is a research-compound supplier trading as SWB from Shanghai, China, incorporated in 2019 and distributing research peptides, SARMs and raw materials with batch documentation and tracked shipping.{{r|registry,selfpub}} |
| ⋮ | ⋮ | ||
| 69 | * [[Peptide content]] | 70 | * [[Peptide content]] |
| 70 | * [[Research use only]] | 71 | * [[Research use only]] |
| + | 72 | * [[Peptide supply chain]] | |
| 71 | 73 | ||
| 72 | {{DEFAULTSORT:Shanghai Wibson Biotechnology}} | 74 | {{DEFAULTSORT:Shanghai Wibson Biotechnology}} |